Ovid Therapeutics Inc. (24) | Human Resources (10)

Browse by Subcategory

Recent Contracts

Non-Employee Director Compensation Policy, effective May 5, 2022 (Filed With SEC on May 10, 2022)
Amended and Restated Executive Employment Agreement between the Company and Jeffrey Rona, effective June 2, 2021 (Filed With SEC on August 16, 2021)
Separation and Consulting Agreement, by and between the Company and Matthew During, dated as of March 24, 2019 (Filed With SEC on May 7, 2019)
Non-Employee Director Compensation Policy, effective May 6, 2021 (Filed With SEC on November 10, 2021)
Executive Employment Agreement between the Company and Jeff Rona, effective September 30, 2020 (Filed With SEC on March 15, 2021)
Executive Employment Agreement between the Company and Jason Tardio, effective October 21, 2019 (Filed With SEC on March 15, 2021)
Amended and Restated Executive Employment Agreement between the Company and Thomas Perone, effective January 1, 2020 (Filed With SEC on March 15, 2021)
Non-Employee Director Compensation Plan (Filed With SEC on March 11, 2020)
Second Amended and Restated Executive Employment Agreement between the Company and Amit Rakhit, effective November 1, 2019 (Filed With SEC on March 11, 2020)
Third Amended and Restated Executive Employment Agreement between the Company and Tim Daly, effective December 18, 2019 (Filed With SEC on March 11, 2020)